Peter Thiel is doubling down on the emerging “corporate Ethereum treasury” trade. A fresh Schedule 13G filed with the US Securities and Exchange Commission shows entities affiliated with Thiel’s Founders Fund have amassed a 7.5% passive stake in 180 Life Sciences Corp. (Nasdaq: ATNF), which is rebranding as ETHZilla and pivoting its business to accumulating Ether and generating on-chain yield.

Peter Thiel Doubles Down On Ethereum

The disclosure, signed “/s/ Peter Thiel” on August 11, confirms beneficial ownership across multiple Founders Fund vehicles totaling roughly 11.6 million ATNF shares—7.5% of the float. The market reaction was immediate. ATNF shares more than tripled on Tuesday, closing near $10.24—about 207% above Monday’s close—before cooling in after-hours trading.

ETHZilla’s

See Full Page